• One Health
  • Pain Management
  • Oncology
  • Geriatric & Palliative Medicine
  • Ophthalmology
  • Anatomic Pathology
  • Poultry Medicine
  • Infectious Diseases
  • Dermatology
  • Theriogenology
  • Nutrition
  • Animal Welfare
  • Radiology
  • Internal Medicine
  • Small Ruminant
  • Cardiology
  • Dentistry
  • Feline Medicine
  • Soft Tissue Surgery
  • Urology/Nephrology
  • Avian & Exotic
  • Preventive Medicine
  • Anesthesiology & Pain Management
  • Integrative & Holistic Medicine
  • Food Animals
  • Behavior
  • Zoo Medicine
  • Toxicology
  • Orthopedics
  • Emergency & Critical Care
  • Equine Medicine
  • Pharmacology
  • Pediatrics
  • Respiratory Medicine
  • Shelter Medicine
  • Parasitology
  • Clinical Pathology
  • Virtual Care
  • Rehabilitation
  • Epidemiology
  • Fish Medicine
  • Diabetes
  • Livestock
  • Endocrinology

Feed Supplements

Article

Pharmacia Animal Health announces it has received approval from the U.S. Food and Drug Administration for five new MGA® Premix (melengestrol acetate) combinations.

Pharmacia Animal Health announces it has received approval from the U.S.Food and Drug Administration for five new MGA® Premix (melengestrolacetate) combinations. The new premixes include: · MGA + Rumensin+Tylan - This three-way combination is now approved for use as a singleliquid supplement. · MGA + Tylan ­ This combination is now labeledfor use as a single liquid supplement. · MGA + Tylan ­ The completedose range for Tylan (60 to 90 mg/head/day) is now approved in both liquidand dry feeds. · MGA + Rumensin ­ A coccidiosis claim has beenadded for this two-way combination in both liquid and dry feeds. ·MGA + Rumensin + Tylan ­ A new coccidiosis claim has been added, alongwith the full Tylan dose range in both liquid and dry feeds. MGA is a feedadditive that suppresses estrus in feedlot heifers, while simultaneouslyimproving rate of gain and feed efficiency, the company says.

For fastest response call (800) 793-0596 or visit the Web site at

Related Videos
© 2023 MJH Life Sciences

All rights reserved.